The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

Completion of preclinical data package for RAD 402

by admin December 10, 2024
December 10, 2024
Completion of preclinical data package for RAD 402

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Lundin Mining to Divest Neves-Corvo and Zinkgruvan Operations for US$1.52 Billion
next post
CLEO Further Expands Ovarian Cancer Trial with Siles Health

Related Posts

SOURCE ROCK ROYALTIES ANNOUNCES 2023 RESULTS INCLUDING RECORD...

April 23, 2024

Cyclone Metals

December 7, 2023

Group Eleven Announces C$5M Bought Deal Private Placement

July 22, 2025

Lithium Universe Limited (ASX: LU7) – Trading Halt

September 20, 2024

CY25 Production Program Underway, First Gold Pour in...

January 29, 2025

EU and Serbia Sign Lithium Deal to Bolster...

July 24, 2024

Jindalee Lithium

December 7, 2023

QX Resources

January 12, 2024

AI Market 2024 Year-End Review

December 18, 2024

5 Top Weekly TSX Stocks: Oil and Gas...

November 14, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,484)
    • Investing (3,794)
    • Politics (5,086)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved